Compared to Estimates, Nordson (NDSN) Q2 Earnings: A Look at Key Metrics

Core Insights - Nordson reported revenue of $682.94 million for the quarter ended April 2025, marking a year-over-year increase of 5% and exceeding the Zacks Consensus Estimate by 1.39% [1] - The company's EPS for the same period was $2.42, up from $2.34 a year ago, with a surprise of 2.54% over the consensus estimate [1] Financial Performance Metrics - Net Sales in Industrial Precision Solutions were $318.85 million, below the average estimate of $322.96 million, reflecting a year-over-year decline of 13.1% [4] - Net Sales in Advanced Technology Solutions reached $161.28 million, surpassing the average estimate of $142.32 million, with a year-over-year increase of 40.6% [4] - Net Sales in Medical and Fluid Solutions totaled $202.81 million, slightly below the average estimate of $204.99 million, showing a year-over-year growth of 20% [4] Operating Profit Analysis - Operating profit for Advanced Technology Solutions was $31.56 million, exceeding the average estimate of $27.56 million [4] - Operating profit for Medical and Fluid Solutions was $56.81 million, also above the average estimate of $55.41 million [4] - Operating profit for Industrial Precision Solutions was $95.72 million, falling short of the average estimate of $108.47 million [4] - Corporate operating loss was reported at -$15.34 million, better than the average estimate of -$16.33 million [4] Stock Performance - Nordson's shares have returned +4.9% over the past month, compared to a +7.4% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]